2Q21: Holding Out For Emerging CatalystsDespite delivering washed-out results for 2Q21, GENM has slowly regained its form and we remain confident on its ability to generate positive cash flows and sail beyond COVID-19's hurdles. With the pace of the nation's vaccination programme accelerating, we expect solid recovery and various catalysts in 2H21, including the reopening […]

Read more of this post